Atlas Trials

UNITE Study: Understanding New Interventions With GBM ThErapy

Clinical trial NCT03419403 · TERMINATED

Trial details

NCT number
NCT03419403
Sponsor
AbbVie
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Glioblastoma Multiforme
Start date
2018-07-30
Primary completion
2019-09-05
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.